Now to today’s question: Does moving cannabis to Schedule III hand control of the industry to Big Pharma?That concern has been circulating widely, but this episode of TDR Cannabis in Five walks through why the fear doesn’t line up with how U.S. law actually works. The breakdown is based on analysis from Kyle Sherman of Flowhub, who lays out where the confusion starts — and why it keeps spreading.The core issue, as Sherman explains, is that three separate legal systems are often treated as one: the Controlled Substances Act, the FDA drug approval process, and state cannabis regulation. While these systems interact, they operate independently. Blurring them together is what fuels the takeover narrative.The episode explains what Schedule III does — and just as importantly, what it does not do. Rescheduling acknowledges medical use at the federal level and lowers regulatory friction, but it does not federalize state cannabis markets, require pharmacy-only sales, or place dispensaries under FDA control.The discussion also covers why state cannabis programs have operated for years under federal enforcement discretion, why FDA authority applies to drugs rather than cannabis broadly, and why any true shift toward a pharmaceutical-only model would require explicit action from Congress.The takeaway is straightforward: Schedule III is a classification update, not a handoff. It opens optional pathways for research and tax relief while leaving state systems intact.#CannabisRescheduling #ScheduleIII #CannabisPolicy #CannabisIndustry #280ETax #StateCannabis #FederalCannabisLaw #BigPharmaMyth #Flowhub #TDRCannabisInFiveWant to see last week's recap?   • Trump Puts Cannabis Rescheduling Back in F...  Want to see more Cannabis Reform videos?   • CRS Warns Federal Hemp Ban Hard to Enforce...     • Why Cannabis Messaging Needs a Reset | TDR...     • What Cannabis Rescheduling Actually Means ...     • Texas Tightens Hemp Rules as Med Program E...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...